NeuroBo Pharmaceuticals (NRBO) Earnings Date & Reports

A.I. Advisor

published Earnings

NRBO is expected to report earnings to rise 33.33% to -11 cents per share on March 29

NeuroBo Pharmaceuticals NRBO Stock Earnings Reports

Q4'23

Est.

$-0.12

Q3'23

Beat

by $0.02

Q2'23

Beat

by $0.11

Q1'23

Beat

by $0.53

Q4'22

Beat

by $6.13

The last earnings report on November 13 showed earnings per share of -9 cents, beating the estimate of -10 cents. With 60.72K shares outstanding, the current market capitalization sits at 28.49M.

View a ticker or compare two or three

Compare

NRBO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NRBO
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

545 Concord Avenue

Phone

+1 857 702-9600

Employees

Web

https://www.neurobopharma.com